ID

45987

Descripción

Principal Investigator: Paul K. Paik, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA MeSH: Squamous Cell Carcinoma,Nonsmall Cell Lung Cancer https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000907 Putative oncogenic pathways in squamous cell lung cancer have been recently characterized, although their biologic repercussions in patients is largely unknown. This study sought to discover potential clinical manifestations of major pathways in squamous cell lung cancer, particularly the PI3K pathway. Two key findings emerged: patients with stage IV squamous cell lung cancer whose tumors harbored upstream PI3K aberrations had significantly worse survival and a higher burden of metastatic disease. In addition, brain metastases were significantly more common in these patients than in others. Paired lung primary/brain metastasis genotyping, including RNA sequencing and whole exome sequencing, uncovered a high degree of genetic heterogeneity between lung/brain pairs, and identified potential regulators of the metastatic process to brain.

Link

dbGaP study=phs000907

Palabras clave

  1. 6/4/24 6/4/24 - Madita Rudolph
Titular de derechos de autor

Paul K. Paik, MD, Memorial Sloan Kettering Cancer Center, New York, NY, USA

Subido en

6 de abril de 2024

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

dbGaP phs000907 Brain Metastases in Squamous Cell Lung Cancers

Eligibility Criteria

Inclusion and exclusion criteria
Descripción

Inclusion and exclusion criteria

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0680251
Inclusion criteria: 1) Signed an institutional biospecimen utilization protocol (MSK IRB 06-107) 2) Stage IV squamous cell lung cancer pathologic diagnosis 3) Availability of respected brain metastasis and lung primary tumor
Descripción

Elig.phs000907.v1.p1.1

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1512693
UMLS CUI [1,2]
C0021430
UMLS CUI [2,1]
C1512693
UMLS CUI [2,2]
C0149782
UMLS CUI [2,3]
C0441772
UMLS CUI [2,4]
C1521733
UMLS CUI [2,5]
C0011900
UMLS CUI [3,1]
C1512693
UMLS CUI [3,2]
C0470187
UMLS CUI [3,3]
C0220650
UMLS CUI [3,4]
C0242379
UMLS CUI [3,5]
C0475447

Similar models

Eligibility Criteria

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
Inclusion and exclusion criteria
C1512693 (UMLS CUI [1,1])
C0680251 (UMLS CUI [1,2])
Elig.phs000907.v1.p1.1
Item
Inclusion criteria: 1) Signed an institutional biospecimen utilization protocol (MSK IRB 06-107) 2) Stage IV squamous cell lung cancer pathologic diagnosis 3) Availability of respected brain metastasis and lung primary tumor
boolean
C1512693 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1512693 (UMLS CUI [2,1])
C0149782 (UMLS CUI [2,2])
C0441772 (UMLS CUI [2,3])
C1521733 (UMLS CUI [2,4])
C0011900 (UMLS CUI [2,5])
C1512693 (UMLS CUI [3,1])
C0470187 (UMLS CUI [3,2])
C0220650 (UMLS CUI [3,3])
C0242379 (UMLS CUI [3,4])
C0475447 (UMLS CUI [3,5])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial